Dixon Hubard Feinour & Brown Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Dollar General
DG
|
+$7.61M |
| 2 |
Verizon
VZ
|
+$5.18M |
| 3 |
Vanguard FTSE Emerging Markets ETF
VWO
|
+$5.06M |
| 4 |
Medpace
MEDP
|
+$4.1M |
| 5 |
Atlassian
TEAM
|
+$1.03M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
WCG
Wellcare Health Plans, Inc.
WCG
|
+$5.43M |
| 2 |
Supernus Pharmaceuticals
SUPN
|
+$2.08M |
| 3 |
Stryker
SYK
|
+$456K |
| 4 |
Invesco QQQ Trust
QQQ
|
+$439K |
| 5 |
Zebra Technologies
ZBRA
|
+$271K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 23.08% |
| 2 | Technology | 18.24% |
| 3 | Financials | 8.98% |
| 4 | Industrials | 8.79% |
| 5 | Consumer Discretionary | 8.71% |
Similar funds
Dixon Hubard Feinour & Brown's Q1 2019 Portfolio in Review
As of Q1 2019, Dixon Hubard Feinour & Brown held 180 positions worth $332M, up 23% from $270M the previous quarter. Its ten largest holdings account for 29% of the portfolio.
Dixon Hubard Feinour & Brown deployed $20.2M of net new capital in Q1 2019, opening 17 new positions and adding to 68 existing holdings. Its largest new stake was Dollar General: 65,386 shares worth $7.8M.
By sector, the portfolio is most concentrated in Healthcare at 23% of assets, down from 25% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was Stryker, an estimated $456K trimmed.
- Dixon Hubard Feinour & Brown's largest Q1 2019 buy was Dollar General: 65,386 shares worth $7.8M.
- Dixon Hubard Feinour & Brown added most to Verizon in Q1 2019, an estimated $5.18M increase.
- Dixon Hubard Feinour & Brown's biggest Q1 2019 reduction was Stryker, cutting an estimated $456K.
- Dixon Hubard Feinour & Brown fully exited Wellcare Health Plans, Inc. in Q1 2019, selling an estimated $5.43M.
- Dixon Hubard Feinour & Brown's ten largest holdings make up 29% of its $332M portfolio in Q1 2019.
- Dixon Hubard Feinour & Brown opened 17 new positions and closed 5 in Q1 2019.
- Dixon Hubard Feinour & Brown's portfolio value rose 23% quarter-over-quarter to $332M.
Based on Dixon Hubard Feinour & Brown's 13F filing for Q1 2019, filed 17 May 2019.